Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis - PubMed (original) (raw)

. 1981 Nov;219(2):299-308.

Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis

J W Aiken et al. J Pharmacol Exp Ther. 1981 Nov.

No abstract available

PubMed Disclaimer

Similar articles

Cited by

MeSH terms

Substances

LinkOut - more resources